Immune‐related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.806
Abstract: A 66-year-old man with chronic myelomonocytic leukaemia (CMML) presented with myalgias and acute-onset shortness of breath, profound orthopnoea, and bilateral pedal oedema of 1 day’s duration. He had been diagnosed with CMML a year and… read more here.
Keywords: heart; reference range; myelomonocytic leukaemia; chronic myelomonocytic ... See more keywords
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia
Sign Up to like & getrecommendations! Published in 2018 at "Wiener Klinische Wochenschrift"
DOI: 10.1007/s00508-018-1315-2
Abstract: SummaryChronic myelomonocytic leukaemia is a rare disease and data on the treatment are often extrapolated from myelodysplastic syndrome studies. Although several scores exist for the prognosis of overall survival in chronic myelomonocytic leukaemia, so far there… read more here.
Keywords: risk; time first; treatment; myelomonocytic leukaemia ... See more keywords
Chronic myelomonocytic leukaemia followed by blastic plasmacytoid dendritic cell neoplasm
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15794
Abstract: A 74-year-old patient was hospitalised for the investigation of generalised lymphadenopathy and cutaneous manifestations (red and inflammatory nodules, erythema in 12 different localizations) 2 years after a diagnosis of chronic myelomonocytic leukaemia (CMML)-1 with a… read more here.
Keywords: blastic plasmacytoid; plasmacytoid dendritic; myelomonocytic leukaemia; bpdcn ... See more keywords
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.16175
Abstract: The landscape of medical sequencing has rapidly changed with the evolution of next generation sequencing (NGS). These technologies have contributed to the molecular characterization of the myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML), through… read more here.
Keywords: myelodysplastic syndromes; guidelines use; spanish guidelines; myelomonocytic leukaemia ... See more keywords
Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16790
Abstract: Outcomes in chronic myelomonocytic leukaemia (CMML) are highly variable and may be affected by comorbidity. Therefore, prognostic models and comorbidity indices are important tools to estimate survival and to guide clinicians in individualising treatment. In… read more here.
Keywords: index; nationwide population; comorbidity; myelomonocytic leukaemia ... See more keywords
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemia
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15055
Abstract: care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945–73.e33. 4 The Australasian College of Dermatologists. The Australasian College of Dermatologists Position Statement: isotretinoin for treatment of acne. 2018. Available from:… read more here.
Keywords: cutis presenting; presenting sign; chronic myelomonocytic; myelomonocytic leukaemia ... See more keywords